Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival. (Q39639581)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 March 2012

Language	Label	Description	Also known as
English	Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival.	scientific article published on 18 March 2012

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

based on heuristic

inferred from title

Costas Giaginis

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Stamatios Theocharis

6

object named as

Stamatios Theocharis

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Ekaterini Politi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Paraskevi Alexandrou

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

John Sfiniadakis

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Gregory Kouraklis

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

18 March 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Pathology Oncology Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

875-883

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

https://scigraph.springernature.com/pub.10.1007/s12253-012-9517-9

0 references

The PPARs: from orphan receptors to drug discovery

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

The organization, promoter analysis, and expression of the human PPARgamma gene

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

PPARs and the orchestration of metabolic fuel selection

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

PPARgamma as a therapeutic target for tumor angiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Peroxisome proliferator-activated receptor-gamma ligands as bone turnover modulators

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

PPARs and other nuclear receptors in inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

The impact of declining smoking on radon-related lung cancer in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Epidemiology of lung cancer: looking to the future.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Role of nuclear receptors in lung tumourigenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Peroxisome proliferator-activated receptors in lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Selective activation of PPARgamma in breast, colon, and lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinoma: correlation with histological type and grade

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Revisions to the TNM staging of non-small cell lung cancer: rationale, clinicoradiologic implications, and persistent limitations.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients' survival.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Chemosensitivity and p53-Bax pathway-mediated apoptosis in patients with uterine cervical cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

The role of Bcl-2 family members in tumorigenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Ganciclovir augments the lytic induction and apoptosis induced by chemotherapeutic agents in an Epstein-Barr virus-infected gastric carcinoma cell line

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Receptor Ck-dependent signaling regulates hTERT gene transcription.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Differential expression of inducible nitric oxide synthase and peroxisome proliferator-activated receptor gamma in non-small cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Expression of a peroxisome proliferator-activated receptor gamma 1 splice variant that was identified in human lung cancers suppresses cell death induced by cisplatin and oxidative stress.

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

p53 and its downstream proteins as molecular targets of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Impact of molecular pathology on the clinical management of lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

The role of p53 in treatment responses of lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS12253-012-9517-9

21 January 2018

Molecular pathology of non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel expression and function of peroxisome proliferator-activated receptor gamma (PPARgamma) in human neuroblastoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PPARgamma ligands enhance TRAIL-induced apoptosis through DR5 upregulation and c-FLIP downregulation in human lung cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peroxisome proliferator-activated receptors (PPAR) agonists affect cell viability, apoptosis and expression of cell cycle related proteins in cell lines of glial brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peroxisome proliferator activated receptor-γ (PPAR-γ) mediates the action of gamma linolenic acid in breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Seventh edition of the cancer staging manual and stage grouping of lung cancer: quick reference chart and diagrams

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel PPAR alpha/gamma dual agonist inhibits cell growth and induces apoptosis in human glioblastoma T98G cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PPAR-gamma signaling pathway in placental development and function: a potential therapeutic target in the treatment of gestational diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22426809

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12253-012-9517-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426809%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39639581&oldid=2032603017"